Peptides for Weight Loss in Australia
Evidence Rating
Evidence Rating
Weak
Minimal evidence, failed trials, or very small effects
AOD-9604 is the only weight loss peptide with clinical trial data, but its pivotal Phase IIb trial (n=536) failed in 2007 and development was terminated. BPC-157 has zero human evidence for weight loss. CJC-1295/Ipamorelin elevate growth hormone but no controlled trials show weight loss.
Peptides for Weight Loss Key Facts
No reliable evidence they do
AOD-9604 is the only peptide with weight loss trial data, but its pivotal Phase IIb trial (536 participants) failed in 2007. Development was terminated. Early trials showed ~2 kg benefit, which is clinically trivial.
Growth hormone pathways
AOD-9604 mimics a growth hormone fragment. CJC-1295/Ipamorelin stimulate growth hormone release. BPC-157 is for tissue healing with no weight loss mechanism. None have proven weight loss in controlled trials.
Significant safety and legal concerns
All weight loss peptides are Schedule 4 in Australia. BPC-157 was moved to Schedule 4 in June 2024. Risks include immunogenicity, anaphylaxis (CJC-1295), and cardiovascular effects. "Research peptides" are unregulated and may be contaminated.
Prescription-only (Schedule 4)
All weight loss peptides are Schedule 4 (prescription-only) substances. The TGA has fined peptide clinics over $1 million for advertising breaches. Buying "research peptides" without a prescription is illegal.
$150-450 per month
Available only through clinics. Costs are high and not covered by PBS or private health insurance for weight loss purposes.
Yes, mandatory
All peptides discussed here are Schedule 4 substances requiring a prescription from a registered medical practitioner.
How Peptides for Weight Loss Claims to Work
AOD-9604 is a fragment of human growth hormone claimed to stimulate fat breakdown without growth hormone side effects. CJC-1295/Ipamorelin stimulate growth hormone release, which is claimed to increase fat metabolism. BPC-157 is marketed for tissue healing with no plausible weight loss mechanism.
What the Research Shows
AOD-9604 Phase IIb trial
Pivotal trial with 536 participants FAILED to demonstrate statistically significant weight loss. Development was terminated. Earlier small trials showed approximately 2 kg benefit, which is clinically trivial.
536 participants
BPC-157 weight loss evidence
Zero human studies for weight loss. All research is animal-only, focused on tissue healing (tendons, gut), not body composition. Marketing BPC-157 for weight loss has no scientific basis.
CJC-1295/Ipamorelin growth hormone studies
Proven to elevate growth hormone 3-5x. However, no controlled trials demonstrate this translates to meaningful fat loss. FDA has warned of immunogenicity/anaphylaxis risk and cardiovascular effects.
Source data from published peer-reviewed studies. Links open in a new tab to external medical databases.
Side Effects & Risks
AOD-9604
- Injection site reactions
- Headache
- Chest tightness (reported in trials)
CJC-1295/Ipamorelin
- Immunogenicity and anaphylaxis risk (FDA warning)
- Cardiovascular effects
- Water retention and joint pain
- Contraindicated in cancer patients (growth hormone stimulation)
General peptide risks
- "Research peptides" may be contaminated or mislabelled
- Self-injection risks (infection, incorrect dosing)
- No long-term safety data for weight loss use
Australian Regulatory Status
Frequently Asked Questions
Other Supplements Reviewed
Berberine for weight loss
Evidence: Moderate | $35-75/mo
Apple Cider Vinegar for weight loss
Evidence: Weak | $3-25/mo
Protein Powder for weight loss
Evidence: Strong | $30-90/mo
Weight Loss Patches for weight loss
Evidence: None | $10-50/mo
Natural Appetite Suppressants for weight loss
Evidence: Moderate | $10-40/mo
Lemon Balm for weight loss
Evidence: None | $15-40/mo
Pink Salt (Himalayan Salt) for weight loss
Evidence: None | $1-5/mo
Medical disclaimer: This website is for informational purposes only. We are not medical professionals and nothing on this page constitutes medical advice, diagnosis, or treatment. Supplements are not a substitute for evidence-based medical treatment. Always consult a qualified doctor, pharmacist, or accredited practising dietitian before starting any supplement.
Supplements listed as AUST L on the Australian Register of Therapeutic Goods have been assessed by the TGA for safety and quality only, not for efficacy. An AUST L listing does not mean the TGA has verified that a supplement works for weight loss.
Data sourced from PubMed, Cochrane, TGA ARTG, FSANZ, and published clinical trial data. Last reviewed April 2026.